Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
48 pending office actions • 20 clients • 44 examiners • 22 art units • 0 of 48 (0%) have an AI response strategy ready
Sullivan & Worcester LLP has a career total of 609 applications, with a focus on Biotechnology & Pharmaceuticals. The firm has a resolved allowance rate pct of 86.71. This percentage reflects the ratio of allowances to total resolved cases and characterizes the firm's historical performance across its 609 career applications.
The firm averages 4.11 office actions per allowance, indicating the typical number of rejections or objections encountered before a grant. Currently, there are 35 pending office actions. This current workload is part of the firm's broader history and represents the active phase of prosecution for its clients in Biotechnology & Pharmaceuticals.
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 13 (27%) |
| §103 only | 9 (19%) |
| §102 only | 2 (4%) |
| §112 only | 1 (2%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 8 (17%) |
| Multi-statute (no §101) | 13 (27%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG, KAIJIANG | 2 | 77.1% | +34.4% |
| BUNKER, AMY M | 2 | 29.1% | +45.5% |
| RAMADAN, OMAR | 2 | 25.8% | +56.3% |
| MARCETICH, ADAM M | 2 | 72.7% | +18.8% |
| CHAN, KO HUNG | 1 | 66.7% | +15.0% |
| HANDY, DWAYNE K | 1 | 62.6% | +25.1% |
| CABRAL, ROBERT S | 1 | 62.6% | +32.5% |
| CHOI, WON JUN | 1 | 71.8% | +10.6% |
| LAWRENCE, JOHN CALEB | 1 | 100.0% | +0.0% |
| BREWSTER, HAYDEN R | 1 | 62.7% | +46.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 114d overdue |
| 17729760 | SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS | BUNKER, AMY M | 46d overdue |
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | MYERS, CARLA J | 30d overdue |
| 17403811 | CATHETER SYSTEMS AND RELATED METHODS FOR MAPPING, MINIMIZING, AND TREATING CARDIAC FIBRILLATION | LEE, DAVINA EN-YIN | 1d overdue |
| 17901190 | CELLULAR MEASUREMENT CALIBRATION AND CLASSIFICATION | HYUN, PAUL SANG HWA | 8d |
| 18266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | BAUSCH, SARAE L | 12d |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 15d |
| 17947861 | METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID | PAGUIO FRISING, MICHELLE F | 22d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17729760 | SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS | BUNKER, AMY M | 46d overdue |
| 19054047 | COLUMN TUBE HOLDER FOR IMPROVED-ACCURACY ASSAYS | CHAN, KO HUNG | 17d overdue |
| 18087165 | METHODS FOR CANCER TREATMENT | MARCETICH, ADAM M | 5d |
| 19361820 | SANDWICH ASSAYS IN DROPLETS | ZHANG, KAIJIANG | — |
| 19361770 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | ZHANG, KAIJIANG | — |
| 18927689 | SYSTEM AND METHOD FOR TARGET DETECTION WITH APPLICATIONS IN CHARACTERIZING FOOD QUALITY AND IMPROVING FOOD SAFETY | HANDY, DWAYNE K | — |
| 18913441 | Compositions of Hypochlorous Acid (HOCL) and Methods Of Manufacture Thereof | CABRAL, ROBERT S | — |
| 18796943 | SATELLITE COMMUNICATION SYSTEM | CHOI, WON JUN | — |
| Art Unit | Apps |
|---|---|
| 1681 | 4 |
| 1684 | 3 |
| 1683 | 3 |
| 1682 | 3 |
| 1637 | 3 |
| 1797 | 2 |
| 1796 | 2 |
| 3781 | 2 |
| 1613 | 2 |
| 3631 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19361820 | SANDWICH ASSAYS IN DROPLETS | BIO-RAD LABORATORIES, INC. | ZHANG, KAIJIANG | 1684 | §102Other | Non-Final OA | — | Pending | Oct 17, 2025 |
| 19361770 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | ZHANG, KAIJIANG | 1684 | §102Other | Non-Final OA | — | Pending | Oct 17, 2025 |
| 19054047 | COLUMN TUBE HOLDER FOR IMPROVED-ACCURACY ASSAYS | Mercy Bioanalytics, Inc. | CHAN, KO HUNG | 3631 | §103 | Final Rejection | 17d overdue | Pending | Feb 14, 2025 |
| 18927689 | SYSTEM AND METHOD FOR TARGET DETECTION WITH APPLICATIONS IN CHARACTERIZING FOOD QUALITY AND IMPROVING FOOD SAFETY | BIO-RAD LABORATORIES, INC. | HANDY, DWAYNE K | 1798 | §102§103§112DP | Final Rejection | — | Pending | Oct 25, 2024 |
| 18913441 | Compositions of Hypochlorous Acid (HOCL) and Methods Of Manufacture Thereof | Wiab Water Innovation AB | CABRAL, ROBERT S | DP | Non-Final OA | — | Pending | Oct 11, 2024 | |
| 18796943 | SATELLITE COMMUNICATION SYSTEM | Commcrete Ltd. | CHOI, WON JUN | §103§112 | Non-Final OA | — | Pending | Aug 07, 2024 | |
| 18797023 | REMOTE COMMUNICATIONS METHODS | Commcrete Ltd. | LAWRENCE, JOHN CALEB | §103§112 | Non-Final OA | — | Pending | Aug 07, 2024 | |
| 18778205 | DEVICES AND METHODS FOR mtDNA EXTRACTION | Inso Biosciences, Inc. | BUNKER, AMY M | §102§103§112DP | Non-Final OA | — | Pending | Jul 19, 2024 | |
| 18772583 | MIXING DEVICE | Wiab Water Innovation AB | BREWSTER, HAYDEN R | §112DP | Non-Final OA | — | Pending | Jul 15, 2024 | |
| 18653326 | SURGICAL DEVICES FOR SOFT TISSUE AUGMENTATION | Expand Medical Ltd. | BYRD, BRIGID K | 3771 | §102§103§112 | Final Rejection | — | Pending | May 02, 2024 |
| 18627895 | ALGORITHMIC TECHNIQUES FOR DEDUCTION OF FUNCTIONAL CHARACTERISTICS OF CARDIAC TISSUE IN CARDIAC ELECTRICAL FIBRILLATION FROM A DENSELY PACKED ARRAY OF HIGH-RESOLUTION ELECTRODES | Coremap, Inc. | JOHNSON, NICOLE F | 3796 | §103§112Other | Final Rejection | 29d | Pending | Apr 05, 2024 |
| 18435187 | DRAIN FLUIDS FOR DISEASE DIAGNOSIS AND MONITORING | Droplet Biosciences, Inc. | PRIEST, AARON A | 1681 | §102§103 | Final Rejection | — | Pending | Feb 07, 2024 |
| 18580412 | COMPOSITIONS AND METHODS FOR DETECTION OF PANCREATIC CANCER | Mercy Bioanalytics, Inc. | DAUNER, JOSEPH G | §101§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 | |
| 18580440 | COMPOSITIONS AND METHODS FOR DETECTION OF ESOPHAGEAL CANCER | Mercy Bioanalytics, Inc. | WOOLWINE, SAMUEL C | 1681 | §112 | Final Rejection | — | Pending | Jan 18, 2024 |
| 18580427 | COMPOSITIONS AND METHODS FOR DETECTION OF BREAST CANCER | Mercy Bioanalytics, Inc. | CASH, KAILEY ELIZABETH | 1683 | §101§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18580422 | COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER | Mercy Bioanalytics, Inc. | KIM, YOUNG J | 1681 | §101§112 | Final Rejection | 33d | Pending | Jan 18, 2024 |
| 18580444 | COMPOSITIONS AND METHODS FOR DETECTION OF COLORECTAL CANCER | Mercy Bioanalytics, Inc. | HANEY, AMANDA MARIE | 1682 | §101§102§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18542057 | ANALYSIS OF EFFLUENT | Droplet Biosciences, Inc. | RAMADAN, OMAR | §101§102§103§112 | Non-Final OA | — | Pending | Dec 15, 2023 | |
| 18538076 | DIGITAL ANALYSIS OF NUCLEIC ACID MODIFICATION | BIO-RAD LABORATORIES, INC. | LU, FRANK WEI MIN | §102§112 | Non-Final OA | — | Pending | Dec 13, 2023 | |
| 18557630 | THERAPEUTIC COMPOSITIONS FOR TREATING PAIN VIA MULTIPLE TARGETS | Quiver Holdings Inc. | ZARA, JANE J | 1637 | §102§112DP | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18242658 | SYSTEM AND METHOD FOR LEAKAGE CONTROL IN A PARTICLE CAPTURE SYSTEM | BIO-RAD LABORATORIES, INC. | CROW, ROBERT THOMAS | 1683 | §103§112DP | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18240445 | STRUCTURAL VARIANT IDENTIFICATION | Saga Diagnostics AB | FONSECA LOPEZ, FRANCINI ALVARENGA | §101§102§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 | |
| 18240453 | DETECTION OF VARIANT ESR1 SEQUENCES | Saga Diagnostics AB | JONES, CHRISTINE MICHELLE | 1682 | §103§112DP | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18240416 | MULTI-VECTOR DETECTION OF VARIANT SEQUENCES | Saga Diagnostics AB | KALLAL, ROBERT JAMES | 1683 | §101§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18347377 | TISSUE CHAMBER | Applikate Technologies, Inc. | WASHINGTON, BRITNEY NICOLE | 1797 | §102§103 | Final Rejection | 71d | Pending | Jul 05, 2023 |
| 18336198 | SCREENING FOR STRUCTURAL VARIANTS | Molecular Loop Biosciences, Inc. | OYEYEMI, OLAYINKA A | §112DP | Non-Final OA | — | Pending | Jun 16, 2023 | |
| 18266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | The University of Chicago | BAUSCH, SARAE L | 1699 | §101§102§103DP | Final Rejection | 12d | Pending | Jun 10, 2023 |
| 18195048 | CELL CAPTURE SYSTEM AND METHOD OF USE | BIO-RAD LABORATORIES, INC. | FISHER, BRITTANY I | 1796 | §102§103 | Non-Final OA | 41d | Pending | May 09, 2023 |
| 18193934 | BIOPOLYMER SYNTHESIS | Ribbon Biolabs GmbH | GRAFF, SHARON LEVINE | §101§102§103§112 | Non-Final OA | — | Pending | Mar 31, 2023 | |
| 18087165 | METHODS FOR CANCER TREATMENT | Droplet Biosciences, Inc. | MARCETICH, ADAM M | 3781 | §103 | Non-Final OA | 5d | Pending | Dec 22, 2022 |
| 17934428 | THERAPEUTICS FOR HAPLOINSUFFICIENCY CONDITIONS | Quelltx, Inc. | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | 27d | Pending | Sep 22, 2022 |
| 17947881 | DUAL PORT DRAIN | The Washington University | MARCETICH, ADAM M | 3781 | §103 | Non-Final OA | — | Pending | Sep 19, 2022 |
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | The Washington University | MYERS, CARLA J | 1682 | §101§103§112DP | Final Rejection | 30d overdue | Pending | Sep 19, 2022 |
| 17947861 | METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID | The Washington University | PAGUIO FRISING, MICHELLE F | 1651 | §101DP | Non-Final OA | 22d | Pending | Sep 19, 2022 |
| 17901190 | CELLULAR MEASUREMENT CALIBRATION AND CLASSIFICATION | Travera, Inc. | HYUN, PAUL SANG HWA | 1796 | §103§112 | Final Rejection | 8d | Pending | Sep 01, 2022 |
| 17842110 | COMPOSITIONS AND METHODS FOR AERODIGESTIVE TREATMENT | Wiab Water Innovation AB | ANTHOPOLOS, PETER | 1611 | §103 | Final Rejection | — | Pending | Jun 16, 2022 |
| 17837689 | BIOCIDAL COMPOSITIONS AND METHODS OF MAKING THE SAME | Wiab Water Innovation AB | SONG, JIANFENG | 1613 | §103 | Non-Final OA | 22d | Pending | Jun 10, 2022 |
| 17740485 | COMPOSITIONS TARGETING SODIUM CHANNEL 1.6 | Quiver Holdings Inc. | PERSONS, JENNA L | 1637 | §103 | Non-Final OA | — | Pending | May 10, 2022 |
| 17735799 | CELL ACTIVITY MACHINE LEARNING | Quiver Holdings Inc. | PLAYER, ROBERT AUSTIN | 1686 | §103DP | Final Rejection | — | Pending | May 03, 2022 |
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | Travera, Inc. | JARRETT, LORE RAMILLANO | 1797 | §101§103§112DP | Non-Final OA | 114d overdue | Pending | Apr 29, 2022 |
| 17729760 | SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS | BIO-RAD LABORATORIES, INC. | BUNKER, AMY M | 1684 | §102§103§112 | Non-Final OA | 46d overdue | Pending | Apr 26, 2022 |
| 17507102 | COMMON MODE REJECTION CONFIGURATION FOR IMPROVING SPATIAL RESOLUTION | Coremap, Inc. | EVANISKO, GEORGE ROBERT | 3792 | §102§103§112 | Final Rejection | — | Pending | Oct 21, 2021 |
| 17466309 | DISTINGUISHING RARE VARIATIONS IN A NUCLEIC ACID SEQUENCE FROM A SAMPLE | BIO-RAD LABORATORIES, INC. | YU, TIAN NMN | 1681 | §102§103 | Non-Final OA | 47d | Pending | Sep 03, 2021 |
| 17435697 | SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGET ENTITY DETECTION | Mercy Bioanalytics, Inc. | RAMADAN, OMAR | 1678 | §103Other | Non-Final OA | — | Pending | Sep 01, 2021 |
| 17403811 | CATHETER SYSTEMS AND RELATED METHODS FOR MAPPING, MINIMIZING, AND TREATING CARDIAC FIBRILLATION | University Of Vermont And State Agricultural College | LEE, DAVINA EN-YIN | 3794 | §101§103 | Final Rejection | 1d overdue | Pending | Aug 16, 2021 |
| 17322842 | COMPOSITIONS AND METHODS TO DISINFECT, TREAT AND PREVENT MICROBIAL INFECTIONS | Wiab Water Innovation AB | PHAN, DOAN THI-THUC | 1613 | §102§103§112 | Non-Final OA | — | Pending | May 17, 2021 |
| 17244333 | VIRAL TESTING IN SALIVA | The Regents of the University of Colorado | GILL, RACHEL B | 1671 | §103Other | Non-Final OA | — | Pending | Apr 29, 2021 |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | Travera, Inc. | COLEMAN, CHARLES P. | 3683 | §101 | Final Rejection | 15d | Pending | Jan 10, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial